黛力新与多虑平联合治疗心血管疾病焦虑抑郁症状临床探讨.docVIP

  • 19
  • 0
  • 约4.91千字
  • 约 10页
  • 2018-09-28 发布于福建
  • 举报

黛力新与多虑平联合治疗心血管疾病焦虑抑郁症状临床探讨.doc

黛力新与多虑平联合治疗心血管疾病焦虑抑郁症状临床探讨

黛力新与多虑平联合治疗心血管疾病焦虑抑郁症状临床探讨   【摘要】 目的:评估多虑平+黛力新用于心血管疾病伴焦虑抑郁症患者的联治疗效。方法:以患心血管病诱发抑郁、焦虑症状而入本院实施诊疗的82例患者为调研对象,将其分成参照组、分析组,参照组40例施予常规型药物开展治疗,分析组42例增服多虑平+黛力新,比较两种给药方法的疗效情况。结果:用药6周后,分析组患者疗效、三种人格影响因子评估分数均优越于参照组,差异有统计学意义(P0.05)。结论:心血管疾病内科治疗中联合使用多虑平+黛力新,可降低迟滞、睡眠障碍、焦虑绝望等人格影响因子评分,疗效较佳。   【关键词】 多虑平; 黛力新; 联合治疗; 心血管疾病; 焦虑; 抑郁   doi:10.14033/j.cnki.cfmr.2017.5.002 文献标识码 A 文章编号 1674-6805(2017)05-0003-02   Deanxit Associated with Doxepin in the Treatment of Cardiovascular Patients with Anxiety Depression Symptoms/WANG Lu-fang.//Chinese and Foreign Medical Research,2017,15(5):3-4   【Abstract】 Objective:To assess curative effect of Doxepin+Deanxit for cardiovascular patients with anxiety depression.Method:82 patients with cardiovascular disease induced depression and anxiety symptoms in our hospital was selected as the research object,and divided into control group(40 cases) and analysis group(42 cases),control group using routine drug for treatment,analysis group using Doxepin +Deanxi based on routine drug.The curative effect of two groups was compared.Result:After 6 weeks,in analysis group,the curative effect and three kinds of personality factors evaluation scores were superior to control group(P0.05).Conclusion:The combination of Deanxit and Doxepin in cardiovascular internal medicine treatment can reduce lag,sleep disorders,anxiety,despair and other personality factors.Curative effect is better.   【Key words】 Deanxit; Doxepin; Combination therapy; Cardiovascular disease; Anxiety; Depression   First-author’s address:Qujing City First People’s Hospital,Qujing 655000,China   ?瓤屏俅仓卸孕难?管病展开控制治疗时,通常需要兼顾患者心理情绪因素,以防心血管病诱发情绪烦躁、心情低落及抑郁、焦虑等心理方面的负性问题[1]。若患心血管病后,患者出现了以上一系列负性心理,既会加重心血管病病情,又会增加预后医疗难度,使疾病致死率显著增高[2]。本文以患心血管病诱发抑郁、焦虑症状而入本院实施诊疗的82例患者为调研对象,将其分成参照组、分析组,参照组施予常规型药物治疗,分析组增服多虑平+黛力新,评比两种给药方法的疗效,现将本次调研内容作如下阐述。   1 资料与方法   1.1 一般资料   抽选因患心血管病诱发抑郁、焦虑症状而入本院心内科实施诊疗的82例患者,将其分成参照组、分析组,参照组40例:男22例,女18例,年龄48~83岁,平均(67.6±9.15)岁;病程1~12年,平均(3.40±1.54)年;HAMD量化分20~32分,平均(24.50±2.47)分。分析组42例:男2

文档评论(0)

1亿VIP精品文档

相关文档